16-89183555-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The ENST00000289746.3(CDH15):​c.365C>T​(p.Ala122Val) variant causes a missense change. The variant allele was found at a frequency of 0.000139 in 1,614,124 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A122P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00060 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000090 ( 0 hom. )

Consequence

CDH15
ENST00000289746.3 missense

Scores

9
10

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:3

Conservation

PhyloP100: 4.43
Variant links:
Genes affected
CDH15 (HGNC:1754): (cadherin 15) This gene is a member of the cadherin superfamily of genes, encoding calcium-dependent intercellular adhesion glycoproteins. Cadherins consist of an extracellular domain containing 5 cadherin domains, a transmembrane region, and a conserved cytoplasmic domain. Transcripts from this particular cadherin are expressed in myoblasts and upregulated in myotubule-forming cells. The protein is thought to be essential for the control of morphogenetic processes, specifically myogenesis, and may provide a trigger for terminal muscle cell differentiation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.025456399).
BS2
High AC in GnomAd4 at 92 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDH15NM_004933.3 linkuse as main transcriptc.365C>T p.Ala122Val missense_variant 4/14 ENST00000289746.3 NP_004924.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDH15ENST00000289746.3 linkuse as main transcriptc.365C>T p.Ala122Val missense_variant 4/141 NM_004933.3 ENSP00000289746 P1
CDH15ENST00000521087.5 linkuse as main transcriptn.1196C>T non_coding_transcript_exon_variant 3/35
CDH15ENST00000524089.1 linkuse as main transcriptn.430C>T non_coding_transcript_exon_variant 4/52

Frequencies

GnomAD3 genomes
AF:
0.000604
AC:
92
AN:
152226
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000196
AC:
49
AN:
250190
Hom.:
1
AF XY:
0.000126
AC XY:
17
AN XY:
135436
show subpopulations
Gnomad AFR exome
AF:
0.00265
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000903
AC:
132
AN:
1461780
Hom.:
0
Cov.:
31
AF XY:
0.0000880
AC XY:
64
AN XY:
727180
show subpopulations
Gnomad4 AFR exome
AF:
0.00215
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000580
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000342
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000604
AC:
92
AN:
152344
Hom.:
1
Cov.:
32
AF XY:
0.000550
AC XY:
41
AN XY:
74504
show subpopulations
Gnomad4 AFR
AF:
0.00204
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000767
Hom.:
0
Bravo
AF:
0.000714
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000280
AC:
34

ClinVar

Significance: Likely benign
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 18, 2017- -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The CDH15 p.Ala122Val variant was identified in 1 of 1294 proband chromosomes (frequency: 0.00077) from unrelated individuals with mild to severe intellectual disability and was not identified in 1600 control chromosomes from healthy individuals (Bhalla_2008_PMID:19012874). The variant was also identified in dbSNP (ID: rs121434541) and ClinVar (classified as pathogenic by OMIM) but was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 65 of 281588 chromosomes (1 homozygous) at a frequency of 0.000231 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 59 of 24942 chromosomes (freq: 0.002365), Latino in 5 of 35422 chromosomes (freq: 0.000141) and Other in 1 of 7216 chromosomes (freq: 0.000139), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), European (non-Finnish) or South Asian populations. Mouse L-cells transfected with CDH15 cDNA containing the A122V change demonstrated a greater than 80% decrease in cell-cell adhesion compared to cells transfected with wildtype CDH15 (Bhalla_2008_PMID:19012874). The p.Ala122 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Intellectual disability, autosomal dominant 3 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 01, 2008- -
CDH15-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 06, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.37
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.025
T
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
0.40
N
MutationTaster
Benign
1.0
A
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-3.2
D
REVEL
Uncertain
0.42
Sift
Uncertain
0.021
D
Sift4G
Uncertain
0.019
D
Polyphen
1.0
D
Vest4
0.40
MVP
0.85
MPC
0.15
ClinPred
0.080
T
GERP RS
3.7
Varity_R
0.35
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121434541; hg19: chr16-89249963; API